These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18470946)

  • 1. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
    Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
    Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment.
    Dequeker E; Cassiman JJ
    Eur J Hum Genet; 1998; 6(2):165-75. PubMed ID: 9781062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing and quality control in diagnostic laboratories.
    Dequeker E; Cassiman JJ
    Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiallelic synthetic quality control material: lessons learned from the cystic fibrosis external quality assessment scheme.
    Berwouts S; Christensen TM; Brandon J; Bejjani BA; Barton DE; Dequeker E
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):579-86. PubMed ID: 21476898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias.
    Seneca S; Morris MA; Patton S; Elles R; Sequeiros J
    Eur J Hum Genet; 2008 Aug; 16(8):913-20. PubMed ID: 18301445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of cystic fibrosis mutation analysis using ABI 3130XL genetic analyzer.
    Huang CK; Pan Q
    Diagn Mol Pathol; 2007 Mar; 16(1):57-9. PubMed ID: 17471160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme.
    Berwouts S; Morris MA; Girodon E; Schwarz M; Stuhrmann M; Dequeker E
    Hum Mutat; 2011 Nov; 32(11):1197-203. PubMed ID: 21796730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for cystic fibrosis: past, present and future.
    Richards CS; Grody WW
    Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing strategies for CFTR molecular testing.
    Gimenez J; Ramos MD; Casals T
    J Cyst Fibros; 2011 Mar; 10(2):143-4. PubMed ID: 21147553
    [No Abstract]   [Full Text] [Related]  

  • 14. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
    Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G
    J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial patterns of cystic fibrosis mutation spectra in European populations.
    Lao O; Andrés AM; Mateu E; Bertranpetit J; Calafell F
    Eur J Hum Genet; 2003 May; 11(5):385-94. PubMed ID: 12734544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis in a southern Brazilian population: characteristics of 90% of the alleles.
    Faucz FR; Gimenez J; Ramos MD; Pereira-Ferrari L; Estivill X; Raskin S; Casals T; Culpi L
    Clin Genet; 2007 Sep; 72(3):218-23. PubMed ID: 17718859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of the cystic fibrosis transmembrane conductance regulator gene in infertile family members of Indian CF patients.
    Sharma N; Singh M; Acharya N; Singh SK; Thapa BR; Kaur G; Prasad R
    Biochem Genet; 2008 Dec; 46(11-12):847-56. PubMed ID: 18810634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
    Slostad J; Stein QP; Flanagan JD; Hansen KA
    Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.